Sutter Health Research Enterprise
2800 L Street, Suite 300
Sacramento, CA, 95816
(916) 454-6822
simr@sutterhealth.org
Dr. Rohatgi is a research oncologist at SIMR.
Sutter Health Research Enterprise
2800 L Street, Suite 300
Sacramento, CA, 95816
(916) 454-6822
simr@sutterhealth.org
Sutter Health Research Enterprise
2800 L Street, Suite 300
Sacramento, CA, 95816
(916) 454-6822
simr@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Lung Cancer (AbbVie M14-239)
Study of Telisotuzumab Vedotin (ABBV-399) in Subjects With Previously Treated c-Met+
Non-Small Cell Lung Cancer
Investigators: Deepti Behl MD, Nitin Rohatgi MD
Status: Active, Recruiting
Novocure LUNAR
Effect of Tumor Treating Fields Concurrent W/ Standard of Care Therapies for Treatment
of Stage 4 NSCLC following Platinum Failure (LUNAR)
Investigators: Deepti Behl MD, Stacy D'Andre MD, Nitin Rohatgi MD, Melissa Williams M.D.
Status: Active, Recruiting
RESILIENT-Ipsen (MM-398-01-03-04)
A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection vs Toptecan
in patients with SCLC
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Rajeswari Chellappah M.D., Brian K. Kim M.D, Jasdeepa Nagi M.D., Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D.
Status: Active, Recruiting
Publications
Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice.
Raloxifene is associated with less side effects than tamoxifen in women with early
breast cancer: a questionnaire study from one physician's practice.
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide,
mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas
Research Studies
Genomic Health Oncotype DX AR-V7
Genomic Health 09-060
Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D., David S Yee M.D., MPH
POLARIS Palbociclib in Real World Practice
Palbociclib in Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter
Non-Interventional Study
Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D.